Cargando…
Treatment of Severe Atopic Dermatitis with Dupilumab in Patients with Advanced Cancer
Atopic dermatitis is a chronic inflammatory intensively pruritic skin disease. Patients with moderate-to-severe atopic dermatitis or with difficult-to-treat areas are candidates for systemic therapy, especially when topical therapy is inadequate. Currently, we have available not only conventional im...
Autores principales: | Tanczosova, Milena, Hugo, Jan, Gkalpakiotis, Spyridon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9918040/ https://www.ncbi.nlm.nih.gov/pubmed/36769838 http://dx.doi.org/10.3390/jcm12031191 |
Ejemplares similares
-
Treatment of Severe Atopic Dermatitis with Dupilumab in Three Patients with Renal Diseases
por: Foti, Caterina, et al.
Publicado: (2022) -
Severe atopic dermatitis and dupilumab
por: Bernardo, Wanderley, et al.
Publicado: (2023) -
Remission of severe atopic dermatitis with dupilumab and rescue tofacitinib therapy
por: Peterson, Danielle M., et al.
Publicado: (2021) -
Efficacy and safety of dupilumab in two adolescents with severe atopic dermatitis
por: Giavina-Bianchi, Mara, et al.
Publicado: (2021) -
Dupilumab in the Treatment of Cheilitis in Atopic Dermatitis Patients
por: Shan, Jinpeng, et al.
Publicado: (2022)